New reportThe strategic guide to royalty financing in biopharma

Read more

This document is provided as a starting point for review by counsel. It is not yet final and should not be relied upon. Final terms will be posted following legal review.

BioPalace · Legal

Refund policy.

Last updated: May 13, 2026

1. No paid products or services on the public website

The BioPalace public website (biopalace.com) does not offer paid products or paid services for purchase. White papers, industry briefings, and other educational materials made available on the public Site are provided free of charge. There is therefore no refund to be processed in connection with anything purchased through the public Site.

2. Securities offerings are not subject to this policy

Investments made through any BioPalace-syndicated offering are not retail purchases and are not governed by this Refund Policy. All investor subscription terms — including rescission rights, withdrawal procedures, cancellation windows, and any return of subscription funds — are set out exclusively in the offering documents delivered to verified accredited investors at the time of subscription (including any private placement memorandum and subscription agreement). Those documents control in the event of any conflict with statements made on the public Site.

3. Future paid features

If BioPalace introduces paid products or services on the public Site in the future (for example, premium research subscriptions), refund terms applicable to those products will be disclosed at the point of purchase and will govern in lieu of this section.

4. Contact

Questions about this policy or about charges that appear to have been processed in error may be directed to husein@biopalace.com.